Markets:

Overview

News

Currencies

International

Treasuries

Cingulate Inc. - Common Stock (NQ:CING)

3.730 +0.060 (+1.63%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cingulate Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions ↗

March 13, 2023

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits...

Via Benzinga

Why Cingulate Shares Are Trading Higher Today ↗

February 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 13, 2023

Via Benzinga

Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of...

Via Benzinga

Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

March 13, 2023

From Indegene Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 10, 2023

Via Benzinga

Cingulate Inc. (NASDAQ: CING) Featured in Coverage of the 35th Annual Roth Conference

February 28, 2023

Via Investor Brand Network

Tesla, Amazon, Union Pacific, Woodside Energy, Cingulate: Why These 5 Stocks Drawing Investors' Attention Today ↗

February 26, 2023

Via Benzinga

Dow Dips 350 Points; S&P 500 Down Over 1% ↗

February 24, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 300 points on Friday. The Dow traded down 1.07% to 32,798.91 while the NASDAQ fell 1.90% to 11,370.53. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 24, 2023

Via Benzinga

Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher ↗

February 24, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also...

Via Benzinga

Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 24, 2023

Gainers Bridger Aerospace Group Holdings, Inc. (NASDAQ: BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.

Via Benzinga

Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today? ↗

February 24, 2023

Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data.

Via InvestorPlace

Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today? ↗

February 24, 2023

SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering.

Via InvestorPlace

Why Is Bridger Aerospace (BAER) Stock Up 84% Today? ↗

February 24, 2023

Bridger Aerospace (BAER) stock is taking off on Friday after a filing revealed an over 22% stake in the company from a group of investors.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 24, 2023

Via Benzinga

Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

February 24, 2023

Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD.

Via Benzinga

Why Is Cingulate (CING) Stock Up 72% Today? ↗

February 24, 2023

Cingulate (CING) stock is on the rise Friday after releasing positive data concerning its ADHD treatment, which is in a Phase 3 trial.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 24, 2023

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 04, 2023

Via Benzinga

Cingulate Kickstarts Pivotal Trial For ADHD Candidate, Data Expected In First Half 2023 ↗

January 04, 2023

Cingulate Inc (NASDAQ: CING) has initiated the first Phase 3 clinical trial of its lead candidate CTx-1301, an extended-release tablet formulation of dexmethylphenidate, a compound approved by the FDA...

Via Benzinga

Over $5 Million Bet On Exicure? Check Out These 4 Penny Stocks Insiders Are Buying ↗

December 20, 2022

Wall Street closed lower for the fourth straight session on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Cingulate: This Company Is Changing The Way Critical ADHD And Anxiety Meds Are Delivered ↗

December 20, 2022

Shane Schaffer, Chairman & CEO of Cingulate, Inc. (NASDAQ: CING), was a guest on Benzinga’s All Access on 12/16/22.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗

January 17, 2023

Via Benzinga

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday ↗

November 23, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...

Via Benzinga

Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

November 22, 2022

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 22, 2022

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.